- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| 20.08. | NewGenIvf Group Ltd - F-1, Registration statement for certain foreign private issuers | 3 | SEC Filings | ||
| 17.08. | NewGenIVF Group Limited: NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor | 1 | GlobeNewswire (USA) | ||
| 17.08. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.07. | NewGenIVF Group Limited: NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million | 385 | GlobeNewswire (Europe) | BANGKOK, July 27, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered... ► Artikel lesen | |
| 27.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | NewGenIVF Group Limited: NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million | 1 | GlobeNewswire (USA) | ||
| 06.07. | NewGenIVF Group Limited: NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million | 2 | GlobeNewswire (USA) | ||
| 01.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 22.06. | NewGenIVF Group Limited: NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization | 268 | GlobeNewswire (Europe) | BANGKOK, June 22, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company") today announced that NewGen's total outstanding shares now stand at 10,073,535 following... ► Artikel lesen | |
| 18.06. | NewGenIVF Group Limited: NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested | 520 | GlobeNewswire (Europe) | K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen's expanded stake and exclusive Asia-Pacific... ► Artikel lesen | |
| 18.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 16.06. | NewGenIVF Group Limited: NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure | 3 | GlobeNewswire (USA) | ||
| 11.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 04.06. | NewGenIVF Group Limited: NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy | 327 | GlobeNewswire (Europe) | NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 04.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 28.05. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 25.05. | K25.ai Receives $2M Investment From NIVF | 1 | FinSMEs | ||
| 22.05. | Singapore's K25.ai secures $2M strategic investment from NIVF | 1 | TechNode | ||
| 21.05. | NewGenIVF Group Limited: NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation | 2 | GlobeNewswire (USA) |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,328 | +0,38 % | Here's Why Teladoc's Integrated Care Business Deserves More Attention | ||
| SERNOVA BIOTHERAPEUTICS | 0,083 | -3,27 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 2,020 | -2,65 % | Cerenome, Inc.: Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment | Capital will support continued CNSide commercial scale-up and development Initial tranche of funding provided at closing with future tranches linked to milestones Forecasted cash runway now into 2028... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,060 | -4,63 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 15,800 | +6,76 % | Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now | ||
| CO-DIAGNOSTICS | 1,120 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 9,962 | -2,43 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,435 | -0,20 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 7,120 | -1,11 % | Lifeward Ltd.: Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy | ||
| CLOVER HEALTH INVESTMENTS | 4,120 | -0,96 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| SENSEONICS | 7,550 | +0,67 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 0,800 | -1,48 % | Tempest Therapeutics Announces Up to $7.5 Million Private Placement | BRISBANE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the "Company"), a clinical-stage biotechnology company pioneering the development of advanced in vivo... ► Artikel lesen | |
| NANO-X IMAGING | 0,724 | 0,00 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| IMUNON | 1,290 | +2,38 % | Imunon, Inc.: IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 |
Das Unternehmen NEWGENIVF GROUP LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,83 % bei einem Aktienkurs von 1,090 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEWGENIVF GROUP LIMITED finden Sie auf Wallstreet Online.